Volume 147, Issue 2, Pages 484-494 (February 2015) Hospitalization and Survival in Patients Using Epoprostenol for Injection in the PROSPECT Observational Study Robert P. Frantz, MD, Robert J. Schilz, DO, PhD, FCCP, Murali M. Chakinala, MD, FCCP, David B. Badesch, MD, FCCP, Adaani E. Frost, MD, FCCP, Vallerie V. McLaughlin, MD, FCCP, Robyn J. Barst, MD, Daniel M. Rosenberg, PhD, Dave P. Miller, MS, Brian K. Hartline, MD, Wade W. Benton, PharmD, Harrison W. Farber, MD, FCCP CHEST Volume 147, Issue 2, Pages 484-494 (February 2015) DOI: 10.1378/chest.14-1004 Copyright © 2015 The American College of Chest Physicians Terms and Conditions
Figure 1 Rates of on-study hospitalizations* (per 1, 000 patient-d) in the PROSPECT cohort by prostacyclin history. *On-study hospitalization defined as those with a date of hospital admission after the date of enrollment into PROSPECT. CHEST 2015 147, 484-494DOI: (10.1378/chest.14-1004) Copyright © 2015 The American College of Chest Physicians Terms and Conditions
Figure 2 A, B, Freedom from hospitalization at 1 y by prostacyclin history (A) and sex (B). CHEST 2015 147, 484-494DOI: (10.1378/chest.14-1004) Copyright © 2015 The American College of Chest Physicians Terms and Conditions
Figure 2 A, B, Freedom from hospitalization at 1 y by prostacyclin history (A) and sex (B). CHEST 2015 147, 484-494DOI: (10.1378/chest.14-1004) Copyright © 2015 The American College of Chest Physicians Terms and Conditions
Figure 3 A, B, One-y survival by prostacyclin history (A) and sex (B). CHEST 2015 147, 484-494DOI: (10.1378/chest.14-1004) Copyright © 2015 The American College of Chest Physicians Terms and Conditions
Figure 3 A, B, One-y survival by prostacyclin history (A) and sex (B). CHEST 2015 147, 484-494DOI: (10.1378/chest.14-1004) Copyright © 2015 The American College of Chest Physicians Terms and Conditions